Amphetamine- type reinforcement by dopaminergic agonists in the rat - PubMed (original) (raw)

Amphetamine- type reinforcement by dopaminergic agonists in the rat

R A Yokel et al. Psychopharmacology (Berl). 1978.

Abstract

Intravenous self-administration of d-amphetamine (0.25 mg/kg/injection) decreased in a dose-related fashion after injections of the dopaminergic agonists apomorphine and piribedil. The dopaminergic agonists appear to suppress amphetamine intake in the same way as do 'free' amphetamine injections, by extending drug satiation in a given interresponse period. Clonidine, an alpha noradrenergic agonist, did not have similar effects. Apomorphine and piribedil did not increase 14C-amphetamine levels in rat brains, nor did they retard disappearance of 14C-amphetamine; thus their amphetamine-like effects are not due to alterations of amphetamine metabolism. Rats responding for amphetamine continued to respond for apomorphine or peribedil when the latter drugs were substituted for the former. Rats experienced in amphetamine self-administration readily initiated and maintained responding for apomorphine and piribedil. The dopaminergic blocker (+)-butaclamol disrupted responding for apomorphine and piribedil, although it produced no marked increase in responding for the dopaminergic agonists, as it does for amphetamine. These data add to the evidence that actions in the dopaminergic synapse account for amphetamine's reinforcing properties.

PubMed Disclaimer

Similar articles

• Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
  Koltai MZ, György L. Koltai MZ, et al. Acta Physiol Acad Sci Hung. 1981;58(3):225-33. Acta Physiol Acad Sci Hung. 1981. PMID: 7348023
• The influence of piribedil (ET495) on components of locomotor activity.
  Jenner P, Marsden CD. Jenner P, et al. Eur J Pharmacol. 1975 Aug;33(1):211-5. doi: 10.1016/0014-2999(75)90160-0. Eur J Pharmacol. 1975. PMID: 1175688
• Catecholamines and self-stimulation: evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine.
  Herberg LJ, Stephens DN, Franklin KB. Herberg LJ, et al. Pharmacol Biochem Behav. 1976 May;4(5):575-82. doi: 10.1016/0091-3057(76)90200-8. Pharmacol Biochem Behav. 1976. PMID: 133356
• Neural mechanisms of the reinforcing action of cocaine.
  Wise RA. Wise RA. NIDA Res Monogr. 1984;50:15-33. NIDA Res Monogr. 1984. PMID: 6440023 Review.
• Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
  Ollat H. Ollat H. J Neurol. 1992;239 Suppl 1:S13-6. doi: 10.1007/BF00819561. J Neurol. 1992. PMID: 1634905 Review.

Cited by

• Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats.
  Wise RA, Murray A, Bozarth MA. Wise RA, et al. Psychopharmacology (Berl). 1990;100(3):355-60. doi: 10.1007/BF02244606. Psychopharmacology (Berl). 1990. PMID: 2315433
• Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats.
  Wise RA, Newton P, Leeb K, Burnette B, Pocock D, Justice JB Jr. Wise RA, et al. Psychopharmacology (Berl). 1995 Jul;120(1):10-20. doi: 10.1007/BF02246140. Psychopharmacology (Berl). 1995. PMID: 7480530
• In vivo analysis of the role of dopamine in stimulant and opiate self-administration.
  Gratton A. Gratton A. J Psychiatry Neurosci. 1996 Jul;21(4):264-79. J Psychiatry Neurosci. 1996. PMID: 8754596 Free PMC article. Review.
• Self-administration of D1 receptor agonists by squirrel monkeys.
  Grech DM, Spealman RD, Bergman J. Grech DM, et al. Psychopharmacology (Berl). 1996 May;125(2):97-104. doi: 10.1007/BF02249407. Psychopharmacology (Berl). 1996. PMID: 8783382
• Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure.
  Nader MA, Mach RH. Nader MA, et al. Psychopharmacology (Berl). 1996 May;125(1):13-22. doi: 10.1007/BF02247388. Psychopharmacology (Berl). 1996. PMID: 8724444

References

1. 1. J Pharm Pharmacol. 1975 Jul;27(7):540-2 - PubMed
2. 1. J Pharmacol Exp Ther. 1954 Mar;110(3):315-26 - PubMed
3. 1. Eur J Pharmacol. 1972 Nov;20(2):195-204 - PubMed
4. 1. J Pharmacol Exp Ther. 1968 May;161(1):122-9 - PubMed
5. 1. Pharmacol Biochem Behav. 1976 May;4(5):611-2 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer